Sirona Biochem (CVE:SBM) Stock Price Down 18.8% – What’s Next?

Sirona Biochem Corp. (CVE:SBM)’s stock price dropped 18.8% during trading on Monday . The stock traded as low as C$0.07 and last traded at C$0.07. Approximately 112,944 shares changed hands during trading, an increase of 44% from the average daily volume of 78,445 shares. The stock had previously closed at C$0.08.

Sirona Biochem Stock Down 18.8 %

The stock’s fifty day moving average is C$0.07 and its two-hundred day moving average is C$0.06. The company has a current ratio of 0.34, a quick ratio of 2.41 and a debt-to-equity ratio of 219.21. The firm has a market cap of C$16.69 million, a P/E ratio of -6.50 and a beta of -0.03.

Sirona Biochem Company Profile

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.